|
1
|
Riquelme I, Letelier P, Riffo-Campos AL,
Brebi P and Roa JC: Emerging role of miRNAs in the drug resistance
of gastric cancer. Int J Mol Sci. 17:4242016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Urrutia R: KRAB-containing zinc-finger
repressor proteins. Genome Biol. 4:2312003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gebelein B, Fernandez-Zapico M, Imoto M
and Urrutia R: KRAB-independent suppression of neoplastic cell
growth by the novel zinc finger transcription factor KS1. J Clin
Invest. 102:1911–1919. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knight RD and Shimeld SM: Identification
of conserved C2H2 zinc-finger gene families in the Bilateria.
Genome Biol. 2:RESEARCH0016. 2001.PubMed/NCBI
|
|
7
|
Cowger JJ, Zhao Q, Isovic M and Torchia J:
Biochemical characterization of the zinc-finger protein 217
transcriptional repressor complex: Identification of a ZNF217
consensus recognition sequence. Oncogene. 26:3378–3386. 2007.
View Article : Google Scholar
|
|
8
|
Huntley S, Baggott DM, Hamilton AT,
Tran-Gyamfi M, Yang S, Kim J, Gordon L, Branscomb E and Stubbs L: A
comprehensive catalog of human KRAB-associated zinc finger genes:
Insights into the evolutionary history of a large family of
transcriptional repressors. Genome Res. 16:669–677. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng Y, Geng H, Cheng SH, Liang P, Bai Y,
Li J, Srivastava G, Ng MH, Fukagawa T, Wu X, et al: KRAB zinc
finger protein ZNF382 is a proapoptotic tumor suppressor that
represses multiple oncogenes and is commonly silenced in multiple
carcinomas. Cancer Res. 70:6516–6526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan Y, Wang YF, Su HF, Fang N, Zou C, Li
WF and Fei ZH: Decreased expression of the long noncoding RNA
LINC00261 indicate poor prognosis in gastric cancer and suppress
gastric cancer metastasis by affecting the epithelial–mesenchymal
transition. J Hematol Oncol. 9:572016. View Article : Google Scholar
|
|
12
|
Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu
Z, Gu Q, Liu B and Yan M: CEACAM6 promotes gastric cancer invasion
and metastasis by inducing epithelial-mesenchymal transition via
PI3K/AKT signaling pathway. PLoS One. 9:e1129082014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimokawa M, Haraguchi M, Kobayashi W,
Higashi Y, Matsushita S, Kawai K, Kanekura T and Ozawa M: The
transcription factor Snail expressed in cutaneous squamous cell
carcinoma induces epithelial-mesenchymal transition and
down-regulates COX-2. Biochem Biophys Res Commun. 430:1078–1082.
2013. View Article : Google Scholar
|
|
14
|
Colas E, Pedrola N, Devis L, Ertekin T,
Campoy I, Martínez E, Llauradó M, Rigau M, Olivan M, Garcia M, et
al: The EMT signaling pathways in endometrial carcinoma. Clin
Transl Oncol. 14:715–720. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen W, Zhang H, Wang J, Cao G, Dong Z, Su
H, Zhou X and Zhang S: Lentiviral-mediated gene silencing of
Notch-4 inhibits in vitro proliferation and perineural invasion of
ACC-M cells. Oncol Rep. 29:1797–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fender AW, Nutter JM, Fitzgerald TL,
Bertrand FE and Sigounas G: Notch-1 promotes stemness and
epithelial to mesenchymal transition in colorectal cancer. J Cell
Biochem. 116:2517–2527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kostina AS, Uspensky VE, Irtyuga OB,
Ignatieva EV, Freylikhman O, Gavriliuk ND, Moiseeva OM, Zhuk S,
Tomilin A, Kostareva AA, et al: Notch-dependent EMT is attenuated
in patients with aortic aneurysm and bicuspid aortic valve. Biochim
Biophys Acta. 1862:733–740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7:872014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Xu M, Zhang X, Chu F and Zhou T:
MAPK/c-Jun signaling pathway contributes to the upregulation of the
anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr
virus-encoded BARF1 in gastric carcinoma cells. Oncol Lett.
15:7537–7544. 2018.PubMed/NCBI
|
|
20
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ying J, Li H, Seng TJ, Langford C,
Srivastava G, Tsao SW, Putti T, Murray P, Chan AT and Tao Q:
Functional epigenetics identifies a protocadherin PCDH10 as a
candidate tumor suppressor for nasopharyngeal, esophageal and
multiple other carcinomas with frequent methylation. Oncogene.
25:1070–1080. 2006. View Article : Google Scholar
|
|
22
|
Xiang T, Li L, Yin X, Yuan C, Tan C, Su X,
Xiong L, Putti TC, Oberst M, Kelly K, et al: The ubiquitin
peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis
through stabilizing p53 and is frequently silenced in breast
cancer. PLoS One. 7:e297832012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tao Q, Huang H, Geiman TM, Lim CY, Fu L,
Qiu GH and Robertson KD: Defective de novo methylation of viral and
cellular DNA sequences in ICF syndrome cells. Hum Mol Genet.
11:2091–2102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tao Q, Swinnen LJ, Yang J, Srivastava G,
Robertson KD and Ambinder RF: Methylation status of the
Epstein-Barr virus major latent promoter C in iatrogenic B cell
lymphoproliferative disease. Application of PCR-based analysis. Am
J Pathol. 155:619–625. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mu H, Wang N, Zhao L, Li S, Li Q, Chen L,
Luo X, Qiu Z, Li L, Ren G, et al: Methylation of PLCD1 and
adenovirus-mediated PLCD1 overexpression elicits a gene therapy
effect on human breast cancer. Exp Cell Res. 332:179–189. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan X, Zhou T, Tai YH, Wang C, Zhao J, Cao
Y, Chen Y, Zhang PJ, Yu M, Zhen C, et al: Elevated expression of
CUEDC2 protein confers endocrine resistance in breast cancer. Nat
Med. 17:708–714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin X, Xiang T, Li L, Su X, Shu X, Luo X,
Huang J, Yuan Y, Peng W, Oberst M, et al: DACT1, an antagonist to
Wnt/β-catenin signaling, suppresses tumor cell growth and is
frequently silenced in breast cancer. Breast Cancer Res.
15:R232013. View Article : Google Scholar
|
|
28
|
Güngör C, Zander H, Effenberger KE,
Vashist YK, Kalinina T, Izbicki JR, Yekebas E and Bockhorn M: Notch
signaling activated by replication stress-induced expression of
midkine drives epithelial-mesenchymal transition and
chemoresistance in pancreatic cancer. Cancer Res. 71:5009–5019.
2011. View Article : Google Scholar : PubMed/NCBI
|
